Human CCL4/MIP-1 beta Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Chemotaxis Induced by CCL4/MIP‑1 beta and Neutral-ization by Human CCL4/MIP‑1 beta Antibody. Recombinant Human CCL4/MIP-1 beta (271-BME) chemoattracts the BaF3 mouse pro-B cell line transfected with human CCR5 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (AR002). Chemotaxis elicited by Recombinant Human CCL4/MIP-1 beta (40 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human CCL4/MIP-1 beta Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-271-NA). The ND50 is typically 0.3-1.5 µg/mL.
CCL4/MIP‑1 beta in Human Alzheimer's Disease Brain. CCL4/MIP-1 beta was detected in immersion fixed paraffin-embedded sections of human Alzheimer's disease brain (hippocampus) using 15 µg/mL Goat Anti-Human CCL4/MIP-1 beta Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-271-NA) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-AEC Cell & Tissue Staining Kit (red; CTS009) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
CCL4/MIP‑1 beta in Human PBMCs. CCL4/MIP-1 beta was detected in immersion fixed human peripheral blood mononuclear cells (PBMCs) stimulated with PHA and monensin using Goat Anti-Human CCL4/MIP-1 beta Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-271-NA) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (yellow; NL001) and counterstained with DAPI (blue). View our protocol for Fluorescent ICC Staining of Non-adherent Cells.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CCL4/MIP-1 beta
CCL4/MIP-1 beta is a beta chemokine that is secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells, and pulmonary smooth muscle cells. It attracts a variety of immune cells to sites of microbial infection as well as to other pathologic inflammation such as allergic asthma and ischemic myocardium. CCL4 is secreted from activated monocytes as a heterodimer with CCL3/MIP-1 alpha. It signals through CCR5, and an N-terminally trimmed form additionally interacts with CCR1 and CCR2. In humans, the ability of CCL4 to bind CCR5 inhibits the cellular entry of M-tropic HIV-1 which utilizes CCR5 as a coreceptor.
Product Datasheets
Citations for Human CCL4/MIP-1 beta Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
14
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Household Contacts of Leprosy Patients in Endemic Areas Display a Specific Innate Immunity Profile
Authors: Anouk van Hooij, Maria Tió-Coma, Els M. Verhard, Marufa Khatun, Khorshed Alam, Elisa Tjon Kon Fat et al.
Frontiers in Immunology
-
Epithelium-innate immune cell axis in mucosal responses to SIV
Authors: Shang L, Duan L, Perkey KE et al.
Mucosal Immunol
-
Chemokines and chemokine receptors expression in the lesions of patients with American cutaneous leishmaniasis
Authors: Nilka Luisa Díaz, Olga Zerpa, Félix Jacobo Tapia
Mem. Inst. Oswaldo Cruz
-
Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia
Authors: A van Hooij, EM Tjon Kon F, M Batista da, R Carvalho B, AC Cunha Mess, AR Gobbo, T Lema, K Bobosha, J Li, X Weng, CG Salgado, JS Spencer, PLAM Corstjens, A Geluk
Sci Rep, 2018-12-18;8(1):17920.
Species: Human
Sample Types: Whole Cells
Applications: Lateral Flow -
An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.
Authors: Rump L, Mattey D, Kehoe O, Middleton J
Cytokine, 2017-09-01;97(0):133-140.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
Authors: Walker W, Kurscheid S, Joshi S, Lopez C, Goh G, Choi M, Barakat L, Francis J, Fisher A, Kozal M, Zapata H, Shaw A, Lifton R, Sutton R, Fikrig E
J Virol, 2015-03-04;89(10):5502-14.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
NK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaques.
Authors: Shang L, Smith A, Duan L, Perkey K, Qu L, Wietgrefe S, Zupancic M, Southern P, Masek-Hammerman K, Reeves R, Johnson R, Haase A
J Immunol, 2014-06-04;193(1):277-84.
Species: Primate - Macaca mulatta (Rhesus Macaque)
Sample Types: Whole Tissue
Applications: IHC -
A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer.
Authors: Dumitru CA, Fechner MK, Hoffmann TK
J. Leukoc. Biol., 2012-01-18;91(4):591-8.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease.
Authors: Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, LaJeunesse C, Lee DC, Draghici S, Gotsch F, Kusanovic JP, Hassan SS, Kim JS
J. Immunol., 2009-03-15;182(6):3919-27.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
Intestinal neuro-epithelial interactions modulate neuronal chemokines production.
Authors: Tixier E, Galmiche JP, Neunlist M
Biochem. Biophys. Res. Commun., 2006-04-04;344(2):554-61.
Species: Human
Sample Types: Whole Cells
Applications: ICC, Neutralization -
The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells.
Authors: Quandt J, Dorovini-Zis K
J. Neuropathol. Exp. Neurol., 2004-04-01;63(4):350-62.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Simian immunodeficiency viruses with defective nef genes show increased susceptibility to the noncytotoxic antiviral activity of CD8+ lymphocytes.
Authors: Binninger-Schinzel D, 2019, Norley S, Adler HS, Oberg HH, Kurth R
2002-03-01;294(1):209-21.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
Authors: Mathieu Claireaux, Rémy Robinot, Jérôme Kervevan, Mandar Patgaonkar, Isabelle Staropoli, Anne Brelot et al.
Nature Communications
-
Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes
Authors: Timothy R. Hammond, Connor Dufort, Lasse Dissing-Olesen, Stefanie Giera, Adam Young, Alec Wysoker et al.
Immunity
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CCL4/MIP-1 beta Antibody
Average Rating: 5 (Based on 1 Review)
Have you used Human CCL4/MIP-1 beta Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: